Bright Minds Biosciences Inc. DRUG
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -17.75M | -19.81M | -14.24M | -8.78M | -6.38M |
| Total Depreciation and Amortization | 55.00K | 52.40K | 53.70K | 54.90K | 91.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -526.50K | 4.49M | 5.09M | 2.10M | 1.04M |
| Change in Net Operating Assets | 363.50K | 903.10K | -220.40K | 409.60K | -387.10K |
| Cash from Operations | -17.86M | -14.37M | -9.31M | -6.21M | -5.63M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -104.80K | -104.00K | -102.30K | -100.10K | -97.90K |
| Issuance of Common Stock | 293.56M | 293.46M | 50.42M | 86.03M | 49.82M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -18.20M | -18.20M | -3.40M | -360.20K | 2.51M |
| Cash from Financing | 200.40M | 200.33M | 33.94M | 61.51M | 37.30M |
| Foreign Exchange rate Adjustments | 4.24M | -934.00K | -1.98M | 211.00K | 607.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 186.79M | 185.03M | 22.64M | 55.51M | 32.28M |